文献速递复苏、休克与脓毒症儿科与产科急症

肾上腺素给药时间与创伤性院外心脏骤停儿童持续自主循环恢复后死亡风险相关

Time to epinephrine treatment is associated with the risk of mortality in children who achieve sustained ROSC after traumatic out-of-hospital cardiac arrest.
PubMed 文献 · Crit Care · 2019-03-27
一句话结论创伤性院外心脏骤停患儿中,早期(<15分钟)肾上腺素虽与持续ROSC相关,但在失血性休克组是死亡风险因素(HR 4.52)。

这项多中心回顾性研究(2003-2014年)纳入509例创伤性院外心脏骤停并接受肾上腺素复苏的儿童(≤19岁),按失血性休克(血丢失>全身液体量30%)分为HS组(n=348,68.4%)和非HS组,分析肾上腺素给药时间(早期<15分钟、中期15-30分钟、晚期>30分钟)与结局的关系。两组的早期肾上腺素均与达到持续ROSC相关(均p<0.05),但与生存或良好神经结局无关(未校正混杂因素)。HS组早期肾上腺素增加心输出量,但诱导代谢性酸中毒并减少尿量(均p<0.05)。校正混杂因素后,HS组早期肾上腺素是死亡风险因素(HR 4.52,95%CI 2.73-15.91)。

要点

  • 创伤性OHCA患儿中68.4%(348/509)存在失血性休克,早期肾上腺素(<15分钟)仅25.7%(131/509)实施。
  • HS组和非HS组早期肾上腺素均与达到持续ROSC相关(均p<0.05),但未校正时与生存或良好神经结局无关。
  • HS组早期肾上腺素使复苏后初期心输出量增加,但诱导代谢性酸中毒并减少尿量(均p<0.05)。
  • 校正混杂因素后,HS组早期肾上腺素是死亡风险因素(HR 4.52,95%CI 2.73-15.91)。
  • 创伤性OHCA合并失血性休克患儿使用早期肾上腺素需权衡ROSC获益与复苏后代谢紊乱及死亡风险。

适用人群与场景

  • 年龄≤19岁、发生创伤性院外心脏骤停并接受肾上腺素复苏的儿童;按血丢失>全身液体量30%分为失血性休克(HS)组和非HS组。

诊断标准与关键阈值

  • 失血性休克(HS)定义:血丢失>全身液体量30%。
  • 肾上腺素给药时间分组:早期<15分钟,中期15-30分钟,晚期>30分钟。

处置流程与药物剂量

  • 对创伤性OHCA患儿,按HS与非HS分组评估肾上腺素给药时机;原文按早期<15分钟、中期15-30分钟、晚期>30分钟分组分析,未给出具体剂量方案。

研究设计与关键结果

  • 多中心回顾性研究(2003-2014年),纳入509例创伤性OHCA并接受肾上腺素复苏的儿童(≤19岁);HS组348例(68.4%),早期肾上腺素131例(25.7%)。
  • HS组和非HS组早期肾上腺素均与达到持续ROSC相关(均p<0.05),但未校正混杂因素时与生存或良好神经结局无关。
  • HS组早期肾上腺素增加心输出量,但诱导代谢性酸中毒并减少尿量(均p<0.05)。
  • 校正混杂因素后,HS组早期肾上腺素是死亡风险因素(HR 4.52,95%CI 2.73-15.91)。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对创伤性OHCA合并失血性休克的患儿,早期(<15分钟)肾上腺素虽与持续ROSC相关,但校正混杂因素后与死亡风险增加相关(HR 4.52,95%CI 2.73-15.91),且复苏后初期出现代谢性酸中毒和尿量减少,床旁决策需权衡ROSC获益与这些不利效应。
  • 对非HS的创伤性OHCA患儿,早期肾上腺素与持续ROSC相关(p<0.05),未校正时与生存或良好神经结局无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The benefits of early epinephrine administration in pediatric with nontraumatic out-of-hospital cardiac arrest (OHCA) have been reported; however, the effects in pediatric cases of traumatic OHCA are unclear. Since the volume-related pharmacokinetics of early epinephrine may differ obviously with and without hemorrhagic shock (HS), beneficial or harmful effects of nonselective epinephrine stimulation (alpha and beta agonists) may also be enhanced with early administration. In this study, we aimed to analyze the therapeutic effect of early epinephrine administration in pediatric cases of HS and non-HS traumatic OHCA.

METHODS: This was a multicenter retrospective study (2003-2014). Children (aged ≤ 19 years) who experienced traumatic OHCA and were administered epinephrine for resuscitation were included. Children were classified into the HS (blood loss > 30% of total body fluid) and non-HS groups. The demographics, outcomes, postresuscitation hemodynamics (the first hour) after the sustained return of spontaneous circulation (ROSC), and survival durations were analyzed and correlated with the time to epinephrine administration (early < 15, middle 15-30, late > 30 min) in the HS and non-HS groups. Cox regression analysis was used to adjust for risk factors of mortality.

RESULTS: A total of 509 children were included. Most of them (n = 348, 68.4%) had HS OHCA. Early epinephrine administration was implemented in 131 (25.7%) children. In both the HS and non-HS groups, early epinephrine administration was associated with achieving sustained ROSC (both p < 0.05) but was not related to survival or good neurological outcomes (without adjusting for confounding factors). However, early epinephrine administration in the HS group increased cardiac output but induced metabolic acidosis and decreased urine output during the initial postresuscitation period (all p < 0.05). After adjusting for confounding factors, early epinephrine administration was a risk factor of mortality in the HS group (HR 4.52, 95% CI 2.73-15.91).

CONCLUSION: Early epinephrine was significantly associated with achieving sustained ROSC in pediatric cases of HS and non-HS traumatic OHCA. For children with HS, early epinephrine administration was associated with both beneficial (increased cardiac output) and harmful effects (decreased urine output and metabolic acidosis) during the postresuscitation period. More importantly, early epinephrine was a risk factor associated with mortality in the HS group.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Lin YR, Wu MH, Chen TY, et al. Time to epinephrine treatment is associated with the risk of mortality in children who achieve sustained ROSC after traumatic out-of-hospital cardiac arrest. Crit Care. 2019. PMID: 30917838. doi:10.1186/s13054-019-2391-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。